ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Real-World Comparison of Bezlotoxumab to Standard of Care Therapy for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence.

Tanner M Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.